Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Cardiac Implants Market Report: Information by Device (Coronary Stents, Prosthetic Heart Valve Devices, & Others), Indication (Arrhythmias, Heart Failure, & Others), End User (Hospitals, Cardiac Care Centers, & Others), & Region­­—Forecast till 2030


ID: MRFR/HC/5263-CR | 163 Pages | Author: Rahul Gotadki| April 2019


Cardiac Implants Market Overview


The Cardiac Implants Market is projected to reach USD 24.83 Billion by 2030 at 6.30% CAGR during the forecast period 2022-2030.Cardiac Implants are devices that can monitor the normal functions of the heart, detect fluctuations, and gives information about the heart. These implants are implanted in the heart to know the information about the heart. Moreover, the cardiac monitoring device implants can be used in the treatment of heart diseases like arrhythmias, myocardial ischemia, and acute myocardial infarction, among others. 


Across the globe, the growing prevalence of cardiac diseases and rise in the older adult population are the major drivers that boost the growth of the market. The high-cost implant devices and risk of injection may be the restraints of the market growth over the forecast period.


COVID-19 Analysis:


Due to the COVID-19 outbreak, most of the markets like chemicals, automobiles, energy & power, agriculture, electronics, and medical implants are witnessing that reduction in growth rate. Due to government directions and hospital guidelines to the COVID-19 affected areas, the vascular procedures are reduced to life or limb salvaging cases. A new vascular procedure, endovascular therapy for triage of vascular surgery patients, should be introduced, but it was postponed due to the coronavirus effect.


The advanced technologies in medical implants can raise the growth of the Cardiac Implants industry. Additionally, availability of good medical facilities, hike in disposable income, awareness about the different types of medical implants is the factors helpful for the Cardiac Implants market growth. With government support, providing medical insurance coverage to downtrodden people for their better health leads to the demand for medical implants.


The Cardiac Implants Market is expected to register a CAGR of 7.82% and is anticipated to reach USD 38,054.3 million by 2023. Cardiac implants are devices implanted in the heart which monitor and maintain the normal functions of the heart. Cardiac implants monitor the condition of the heart, detect fluctuations, and provide this information to the doctor or the health care provider. Additionally, they are used in the treatment of heart diseases such as myocardial ischemia, arrhythmias, and acute myocardial infarction, among others.


The factors boosting the growth of the cardiac implants market include the growing prevalence of cardiac diseases and the growing population of older adults across the globe. Despite the drivers, the high cost associated with cardiac implants and risk of injections due to these implants may restrain the market growth over the forecast period.


Synopsis/Market Dynamics


The growth of the cardiac implants industry is driven by factors such as growing geriatric population coupled with the increasing prevalence of cardiac diseases. Generally, the older population is more susceptible to diseases as with aging, the heart and blood vessels become stiff which can lead to conditions such as heart failure, coronary artery disease, and atrial fibrillation, among others.  According to the data published by the Centers for Disease Control and Prevention (CDC) in 2017, about 2.7 to 6.1 million people in the US had atrial fibrillation, a common form of heart arrhythmia. However, the high cost of cardiac implants are a risk of injections is likely to affect the growth of the market.



Cardiac Implants Market Revenue, by End User, 2017 (USD Mn) Global Cardiac Implants Market Revenue, by End User, 2017 Segmentation

Market Dynamics:


Driver:


Rising Prevalence of Cardiac Disease and Geriatric Population


The rise in older adults and the rising prevalence of chronic diseases are the major drivers of the cardiac implant devices. Geriatric people are highly susceptible to chronic diseases like cardiovascular diseases, endovascular diseases, orthopedic disorders, and dental disorders, which are having the major need for medical implants. Generally, for aged people, dental disorder was a common problem. Hence with a rise in aged people, demand for tooth loss may increase. At the risk of a patient’s cardiac disorder, most healthcare organizations and hospitals prefer cardiovascular implants to provide artificial control on the patient’s heartbeat.


Restraint:


High Cost of Treatment and stringent approval process


Some cardiac patients may affect infections with implantable pacemakers, which makes them avoid these products. Thus reduces the demand for cardiac implants. The high cost of treatment is also a big burden for the normal ones. Hence the demand for cardiovascular implants growth decreases.


Opportunities:


Increase in Awareness and technological advancements


By increasing the awareness of different types of medical implants among healthcare professionals can boost the growth of the cardiac implants industry. By introducing the new advanced technologies in medical implants, the availability of better medical facilities, a large number of cases with damaged organs caused due to different types of accidents are the opportunities to increase the cardiac implants market share.


Cardiac Implants Market Share, by Region, 2017 (%)


Global Cardiac Implants Market Share, by Region, 2017


Technology Analysis


The new advanced technologies in medical implants are expected to increase the growth of the Cardiac Implants Industry.


Study Objectives -



  • To provide detailed information about the Cardiac Implants structure along with various forecast segments and sub-segments.

  • To provide the factors that affect the cardiac implants market share growth.

  • To analyze the cardiac implants market-based porter’s five force analysis, etc.

  • To provide the country-level analysis of the current cardiac implants market size and future prospective.

  • To provide country-level analysis of the cardiac monitoring device implants growth by region, device, indication, and end-user.

  • To provide a strategic profile of the key players in the market, analyze their core competencies, and draw a landscape of the cardiac implants market growth.

  • To track and analyze new product developments, strategic alliances, and research in the cardiac implants market.


Segment Overview:


The segmentation of the cardiac implants market was done based on the indication, device, region, and end-user.


Based on Indication


Based on Indication, the global market is segmented into Arrhythmias, myocardial ischemia, acute myocardial infarction, heart failure, and others.


Based on Device


The cardiac implant devices are segmented into implantable loop recorder, cardiac rhythm management devices, coronary stents, ventricular assist devices, and others.


Based on end-users


On the basis of the end-users, market of cardiac implants is segmented into cardiac care centers, ambulatory centers, hospitals,  academic institutes, home care, and others.


Based on Region


Based on the region, the cardiac implants market is segmented to America, Europe, Asia-Pacific, and the Middle East & Africa. Further, America is segmented into North America and South America, Europe is segmented into Western Europe and Eastern Europe. Out of these, North America is holding the largest market share.


Regional Analysis -


The Cardiac Implants Market is segmented based on the regions as Europe, America, Asia-Pacific, Middle East & Africa. Later, America is segmented into North America and South America. North America is expected to hold the largest market share for its high adoption rates of cardiac implantable electronic devices and an increase in the prevalence of cardiac diseases. In Europe, the global market is to grow for factors like increasing the government’s healthcare sector funds and increasing the number of initiatives for heart patients by the insurance companies.


In Europe 2017, Italy accounted for a market share of 9.9%. Asia-pacific is said to be the fastest-growing market for its increasing geriatric population, increasing medical tourism and change in lifestyle. For the presence of poor and slow developing countries in the Africa region, the Middle East & Africa accounts the least market share.


Competitive Landscape


The prominent and efficient key players in the market are as follows:



  • Abbott (US)

  • Amg International (Germany)

  • Edwards Life Sciences Corporation (US)

  • Braun Melsungen AG (Germany)

  • Biotronik(US)

  • Boston Scientific Corporation (US)

  • LivaNova PLC (UK)

  • Medtronic PLC (US)

  • Syncardia Systems, Inc (Arizona)

  • Terumo Corporation (Japan)


The key strategies followed by the players are product development, innovation, acquisition, and expansion.


One of the leading companies, Medtronic launched an advanced technology ICD device that allows patients to gather information by holding an antenna over the implanted cardiac device.


Recent Developments



  • In July 2018, in China, to enter the drug-eluting stent market, Terumo Corporation acquires China-based Essen Technology.

  • In February 2018, Medtronic launched 2.0mm Drug-Eluting Stent Resolute Onyx in the US. it is used by interventional cardiologists to treat patients with coronary artery disease (CAD).

  • In October 2015, Boston Scientific Corporation received the FDA for Synergy Bioabsorbable Polymer Drug-Eluting Stent System.

  • In August 2019, the U.S. FDA approved a heart implant that offers therapeutic stimulation to advanced heart failure patients. The Barostim Neo System is a cardiac neuromodulator device that stimulates baroreceptors in patients.


Report Overview:


The full report is inclusive of the following:



  • Market Overview

  • COVID-19 Analysis

  • Market Dynamics

  • Technology Analysis

  • Study Objectives

  • Segment Overview

  • Regional Analysis

  • Competitive Landscape

  • Recent Developments

  • Segmentation Table

  • FAQs


Segmentation Table


The research in the segmentation of the global renal disease market is done based on indication, device, end-users, and region.


By Device Type


Coronary stents, Cardiac rhythm management devices, prosthetic heart valve devices, implantable loop recorder, and others.


By Indication Type


Myocardial ischemia, arrhythmias, acute myocardial infarction, heart failure and others.


By end-user


Hospitals, ambulatory centers, cardiac care centers, & home care, and others


By Region


America, Europe, Asia-Pacific, and the Middle-East & Africa

Frequently Asked Questions (FAQ) :

Cardiac implants market is expected to rise to a valuation of more than USD 24.83 Billion by 2030.

The global market is expected to exhibit a strong 6.30% CAGR over the forecast period.

The increasing geriatric population and the increasing prevalence of chronic heart conditions are the major drivers for the global cardiac implants market.

The high costs of cardiac implants are the key restraint against the global cardiac implants market.

North America is likely to hold the largest share in the global cardiac implants market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.